Wikisage, the free encyclopedia of the second generation, is digital heritage
Lamictal XR: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
lamotrigine slow release<ref>https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Lamictal_XR/pdf/LAMICTAL-XR-PI-MG.PDF</ref> | lamotrigine slow release<ref>https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Lamictal_XR/pdf/LAMICTAL-XR-PI-MG.PDF</ref> | ||
risk increases conmmitant administration with valproate<references/> | risk increases conmmitant administration with valproate | ||
Stevens Johnson has been observed in 8 per 1000 cases | |||
<references/> | |||
Revision as of 19:15, 15 April 2016
lamotrigine slow release[1] risk increases conmmitant administration with valproate
Stevens Johnson has been observed in 8 per 1000 cases